The applicants in the Radio Rentals “Rent, Try $1 Buy” class action have flagged the potential for prejudice caused by the respondents’ late evidence, with concerns about their capacity to be ready by the looming trial date if ongoing settlement negotiations hit a dead-end.
The ACCC won’t stand in the way of rural supply giant Landmark’s proposed $469 million takeover of competitor Ruralco, with the competition regulator saying the importance of customer relationships would leave room for independent retailers to compete.
Westpac will pay $13.25 million to settle a class action over alleged losses caused by subsidiary BankSA’s investments in a Ponzi scheme run by convicted fraudster Michael Samra.
The ACCC has reversed course, naming the state of New South Wales in its lawsuit over an allegedly anti-competitive agreement for the privatisation of Port Botany and Port Kembla after previously saying the law did not apply to the state.
In a majority ruling that will have significant ramifications for how companies calculate employees’ personal leave days, the Full Federal Court has found that the method used by food manufacturer Mondelez in granting the entitlement for its Tasmanian shift workers left them worse off than under the Fair Work Act.
National Australia Bank is taking Helen Rosamond’s executive services company Human Group to court in connection with a multimillion dollar fraud against the bank.
Ariosa Diagnostics has asked the Full Federal Court to hear its challenge to a ruling that its Harmony prenatal test infringed Sequenom’s patent for a prenatal genetic test, saying the court’s judgment was attended by “sufficient doubt”.
The CFMEU will fund a landmark multi-million dollar class action against labour hire company Workpac seeking repayment of leave entitlements it claims are owed to more than 600 coalminers, in the latest casual employee challenge to hit the courts.
Coal company Glencore has taken further legal steps to block the Australian Taxation Office from accessing documents related to its offshore affairs, after its bid to shield documents exposed in the Panama Papers leak failed before the High Court.
Global pharmaceutical firm Pfizer is mulling an application to stay a lawsuit by Merck Sharp & Dohme seeking to invalidate a patent related to the blockbuster Prevnar 13 vaccine as it awaits the outcome of similar proceedings in the US.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
